News details

The Defense Health Agency director issued comprehensive clinical guidance to the military departments and medical care providers regarding male testosterone deficiency, establishing uniform screening and treatment pathways across the DHA enterprise and assigning responsibility for compliance.

Original sourceDepartment of Defense ReleasesSource attribution and the original dated record for this item.
Read original source